The uniform approach to breast fine-needle aspiration biopsy

American Journal of Surgery

Volumn 174, Issue 4, 1997, Pages 371-385

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

BREAST; BREAST DISEASE; BREAST TUMOR; CONFERENCE PAPER; CONSENSUS DEVELOPMENT; FEMALE; HUMAN; LABORATORY DIAGNOSIS; METHODOLOGY; NEEDLE BIOPSY; PATHOLOGY; STANDARD;

BIOPSY, NEEDLE; BREAST; BREAST DISEASES; BREAST NEOPLASMS; FEMALE; HUMANS; SPECIMEN HANDLING;

EID: 0031255518     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9610(97)00119-0     Document Type: Note

References (91)

1. Abele JS, Miller TR. Implementation of an outpatient needle aspiration biopsy service and clinic: a personal perspective. In: Schmidt W, ed. Cytopathology Annual. Baltimore: Williams & Wilkins; 1993:43-71.
2. Abele JS, Miller TR, Goodson WH, et al. Fine-needle aspiration of palpable breast masses: a program for staged implementation. Arch Surg. 1983;118:859-863.
3. Abu-Farsakh H, Sneige N, Atkinson EN, Hortobagyi G. Pathologic predictors of tumor response to preoperative chemotherapy in locally advanced breast carcinoma. Breast J. 1995;1:96-101.
4. Al-Kaisi N. The spectrum of "gray zone" in breast cytology. A review of 186 cases of atypical and suspicious cytology. Acta Cytol. 1994;38:898-908.
5. American Joint Committee on Cancer: Manual for Staging for Breast Carcinoma, 3rd ed. 1989.
6. Allen MJ, Thompsin WD, Stuart RC, et al. Management of non-palpable breast lesions detected mammographically. Br J Surg. 1994;81:543-545.
7. Azzarelli A, Guzzon A, Pilotti S, et al. Accuracy of breast cancer diagnosis by physical, radiologic and cytologic combined examinations. Tumori. 1983;69:137-141.
8. Barrows GH, Anderson TJ, Lamb JL, et al. Fine-needle aspiration of breast cancer: relationship of clinical factors to cytology results in 689 primary malignancies. Cancer. 1986;88:1493-1498.
9. Blume E, Artz D. Too many breast biopsies? Watching vs. cutting. J Natl Cancer Inst. 1991;83:1207-1209.
10. Bondeson L, Lindholm K. Aspiration cytology of tubular breast carcinoma. Acta Cytol. 1990;34:15-20.
11. Bottles K, Miller TR, Cohen MB, et al. Fine needle aspiration biopsy. Has its time come? Am J Med. 1986;81:525-531.
12. Cohen MB, Miller TR, Gonzales JM, et al. Fine-needle aspiration biopsy. Lab Med. 1986;110:813-817.
13. Cohen MB, Rodgers C, Hales MS, et al. Influence of training and experience in fine-needle aspiration biopsy of breast: receiver op-crating characteristics curve analysis. Arch Pathol Lab Med. 1987;111:518-520.
14. Dabbs DJ, Silverman JF. Prognostic factors from the fine needle aspirate: breast carcinoma nuclear grade. Diogn Cytopathol. 1994;10:203-208.
15. Dawson AE, Norton JA, Weinberg DS. Comparative assessment of proliferation and DNA content in breast carcinomaby image analysis and flow cytometry. Am J Path. 1990;136:1115-1124.
16. DiPietro S, Fariselle G, Bandieramonte G, et al. Diagnostic efficacy of the clinical-radiological-cytological triad in solid breast lumps: results of a second prospective study on 631 patients. Eur J Surg Oncol. 1987;13:335-340.
17. Dixon JM, Andreson TJ, Lamb J, et al. Fine needle aspiration cytology, in relationship to clinical examination and mammography in the diagnosis of a solid breast mass. Br J Surg. 1984:71:593-596.
18. Dupont WD, Page DL. Risk factors for women with proliferative breast disease. NEJM. 1985;312:145-151.
19. Elledge RM, Allred DC. The p53 tumor suppressor gene in breast cancer. Breast Cancer Res Treat. 1994;32:39-47.
20. 3 J Ultrasound Med. 1990;9:559-568.
21. Frable WJ. Needle aspiration of the breast. Cancer. 1984:53:671-676.
22. Frable WJ. Needle aspiration biopsy. Past, present and future. Hum Pathol. 1989;20:504-517.
23. Giard RWM, Hermans J. The value of aspiration cytologic examination of the breast. A statistical review of the medical literature. Cancer. 1992;69:2104-2110.
24. Goldhirsch A, Wood WC, Senn HJ, et al. Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. J Natl Cancer Irot. 1995;87:1441-1445.
25. Goodson WH, Mailman R, Miller TR. Three year follow up of benign fine needle aspiration biopsies of the breast. Am J Surg. 1987;154:58-61.
26. Hahn P, Hallberg O, Schnurer LB. Combination of clinical examination, mammography and aspiration cytology in the diagnosis of carcinoma of the breast (179 cases). Strohlentherapie. 1980;156:475-479.
27. Harris MW. Personal communication to William H. Goodson, M.D., University of California, San Francisco, July 21, 1988.
28. Hartlaub PP, Wokenstein AS, Laufenburg HF. Obtaining informed consent: it is not simply asking "Do you understand?" J Fam Pract. 1993;36:383-384.
29. Hermansen C, Poulsen HS, Jensen J, et al. Diagnostic reliability of combined physical examination, mammography, and fine- needle puncture ("triple-test") in breast tumors: a prospective study. Cancer. 1987;60:1866-1871.
30. Heuftle MG, Haaga JR. Effect of suction on biopsy sample size. AJR. 1986;147:1014-1016.
31. Idvall I, Ferno M, Sigurdsson H, et al. Fine needle aspiration cytology of breast carcinoma: a pre-operative prognostic tool? Breast. 1995;4:189-195.
32. Ilke F, Veronesi U, Luini A, et al. Preoperative chemotherapy alone and combined with preoperative radiotherapy in small-size breast cancer. Breast J. 1996;2:176-180.
33. Jackman RJ, Nowels KW, Shepard MJ, et al. Stereotaxic large-core needle biopsy of 450 nonpalpable breast lesions with surgical correlation in lesions with cancer or atypical hyperplasia. Radiology. 1994;193:91-95.
34. Joensuu H, Alanen K, Falkmer UG, et al. Effect of DNA ploidy classification on prognosis in breast cancer. Int J Cancer. 1992;52:701-706.
35. Kaufman Z, Shpitz B, Shapiro M, et al. Triple approach in the diagnosis of dominant breast masses: combined physical ex-amination, mammography and fine-needle aspiration. J Surg Oncol. 1994;56:254-257.
36. Kline TS, Kline IK. High risk lesion. In: Guides to Clinical Aspiration Biopsy. New York: Igaku-Shoin; 1989:235-248.
37. Koss LG, Woyke S, Olszewski W. Aspiration Biopsy: Cytologic Interpretation and Histologic Bases. New York: Igaku-Shoin; 1984:53-104.
38. Kreuzer G, Boqui E. Aspiration biopsy cytology, mammography and clinical exploration: a modern set up in diagnosis of tumors of the breast. Acta Cytol. 1976;20:319-323.
39. Lannin DR, Silverman JF, Pories WJ, et al. Cost-effectiveness of fine needle biopsy of the breast. Ann Surg. 1986;203:474-480.
40. Layfield LJ. Can fine-needle aspiration replace open biopsy in the diagnosis of palpable breast lesions? Am J Clin Pathol. 1992;98:145-147.
41. Layfield LJ, Chrischilles EA, Cohen MB, et al. The palpable breast nodule. A cost-effectiveness analysis of alternate diagnostic approaches. Cancer. 1993;72:1642-1651.
42. Layfield LJ, Glasgow BJ, Cramer H. Fine needle aspiration in the management of breast masses. In: Rosen PP, Fechner, eds. Pathology Annual. 1989. Part II. Norwalk, Connecticut: Appleton and Lange; 1989:23-62.
43. Layfield LJ, Parkinson B, Wong J, et al. Mammographically guided fine-needle aspiration biopsy of nonpalpable breast lesions. Can it replace open biopsy? Cancer. 1991;68:2007-2011.
44. Lee KR, Foster RS, Papillo JL. Fine needle aspiration of the breast: importance of the aspirator. Acta Cytol. 1987;31: 281-284.
45. Liberman L, Dershaw DD, Rosen PP, et al. Stereotaxic 14-gauge breast biopsy: how many core biopsy specimens are needed? Radiology. 1994;192:793-795.
46. Liberman L, Dershaw DD, Rosen PP, et al. Stereotaxic core biopsy of breast carcinoma: accuracy in predicting invasion. Radiology. 1995;194:379-381.
47. Liberman L, Cohen MA, Dershaw DD, et al. Atypical ductal hyperplasia diagnosed at Stereotaxic core biopsy of breast lesions: an indication for surgical biopsy. AJR. 1995;164: 1111-1113.
48. Linsk J, Kruezer G, Zajicek J. Cytologic diagnosis in mammary tumors from aspiration biopsy smears. 11. Studies on 210 fibroadenomas and 210 cases of benign dysplasia. Acta Cytol. 1972;16:130-138.
49. Ljung B-M. Thin needle aspiration biopsy. One-hour video covering basic and advanced FNAB techniques. Obtainable from the author at the Dept. Pathology, University of California, San Francisco, CA 94143-0102; (415) 476-5202.
50. Lotan R, Xu XC, Lippman SM, et al. Suppression of retinoic acid receptor B in premalignant oral lesions and its upregulation by isotretinoin. NEJM. 1995;332:1405-1410.
51. Mansour EG, Ravdin PM, Dressier L. Prognostic factors in early breast carcinoma. Cancer. 1994;74(suppl):381-400.
52. Martelli G, Pilotti S. Diagnostic efficiency of physical examination, mammography, fine-needle aspiration cytology (triple-test) in solid breast lumps: an analysis of 1708 consecutive cases. Tumori. 1990;76:476-479.
53. Masood S, Frykberg ER, McLellan GL, et al. Prospective evaluation of radiologically directed fine-needle aspiration biopsy of non-palpable breast lesions. Cancer. 1990;66:1480-1487.
54. Masood S, Frykberg ER, McLellan GL, et al. Cytologic differentiation between proliferative and nonproliferative breast disease in mammographically guided fine-needle aspirates. Diagn Cytopathol. 1991;7:581-590.
55. Masood S. Cytopathology of the Breast. Chicago: ASCP Press; 1996.
56. Masood S. Pathological interpretation of fine needle aspiration cytology, In: Fajardo LL, Willison KM, Pizutiello RJ, eds. A Comprehensive Approach to Stereotactic Breast Biopsy. Cambridge, Mass: Blackwell Science; 1996:225-239.
57. Maygarden SJ, Novotny DB, Johnson DE, et al. Subclassification of benign breast disease by fine needle aspiration cytology: comparison of cytologic and histologic findings in 265 palpable breast masses. Acta Cytol. 1994;38:115-129.
58. Meyer JE, Kopans DB. Analysis of mammographically obvious carcinomas of the breast with benign results on initial biopsy. Surg Gynecol Obstet. 1981;153:157-153.
59. Mitnick J, Roses D, Harris M. A differentiation of post surgical changes from carcinoma of the breast. Surg Gynecol Obstet. 1988;166:549-550.
60. Mitnick JS, Vazquez MF, Narris MN, et al. Differentiation of radial scar from cirrhous carcinoma of the breast: mammographic-pathologic correlation. Radiology. 1989;173: 697-700.
61. Mulford DK, Dawson AE. Atypia in fine needle aspiration cytology of nonpalpable and palpable mammographically detected breast lesions. Acta Cytol. 1994;38(1):9-17.
62. Muss HB, Thor AD, Berry DA, et al. c-erbB-2 Expression and response to adjuvant therapy in women with node-positive early breast cancer. NEJM. 1994;330:1260-1266.
63. O'Shaughnessy JA. Chemoprevention of breast cancer. JAMA. 1996;275:1349-1352.
64. O'Reilly SM, Camplejohn RS, Barnes RR, et al. Node-negative breast cancer: prognostic subgroups defined by tumor size and flow cytometry. J Clin Oncol. 1990;8:2040-2046.
65. Orell S. Fine needle aspiration biopsy in perspective. Pathology. 1982;14:113-114.
66. Palombini L, Fulciniti F, Vetrani A, et al. Fine-needle aspiration biopsies of breast masses. A critical analysis of 1956 cases in 8 years (1976-1984). Cancer. 1988;61:2273-2277.
67. Parker SH, Stavros AT. Needle biopsy techniques. Radiol Clinic N Am. 1995;33:1171-1186.
68. Parker SH, Burbank F, Jackman RJ, et al. Percutaneous large-core breast biopsy: a multi-institutional study. Radiology. 1994;193:359-364.
69. Pennes DR, Naylor B, Rebner M. Fine needle aspiration biopsy of the breast. Acta Cytol. 1989;34:673-676.
70. Pinder SE, Wencyk P, Sibbering DM, et al. Assessment of the new proliferation marker MIB1 in breast carcinoma using image analysis: association with other prognostic factors and survival. Br J Breast Cancer. 1994;53:146-149.
71. Porter-Jordan K, Lippman ME. Overview of the biologic markers of breast cancer. Hetnatol/Oncol Clin N Am. 1994;8:73-100.
72. Ravdin PM, Chamness GC. The c-erbB-2 proto-oncogene as a prognostic and predictive marker in breast cancer: a paradigm for the development of other macromolecular markers. A review. Gene. 1995;159:19-27.
73. Reiner A, Reiner G, Spona J, et al. Estrogen receptor immunocytochemistry for preoperative determination of estrogen receptor status on fine needle aspirates of breast cancer. Am J Clin Pathol. 1987;88:399-404.
74. Robinson JA, McKee G, Nichols A, et al. Prognostic value of cytological grading of fine needle aspirates from breast carcinomas. Lancet. 1994;343:947-949.
75. Rosai J. Borderline epithelial lesions of the breast. Am J Surg Path. 1991;15:209-221.
76. Rotstein S, Nilsson B, Svane O, Gustavson-Kadaka E. Clinical examination, mammographic findings and cytological diagnosis in patients with breast disorders. Results of 9 years follow-up. Acta Oncol. 1992;31:393-397.
77. Silverstein MJ, Gierson ED, Waisman JR, et al. Axillary lymph node dissection for T1a breast carcinoma. Cancer. 1994;73:664-667.
78. Silverman J. Breast. In: Bibbo M, ed. Comprehensive Cytopathology. Philadelphia: WB Saunders; 1991.
79. Silverman JF, Masood S, Ducatman BS, et al. Can FNA biopsy separate atypical hyperplasia, carcinoma in situ, and invasive carcinoma of the breast: cytomorphologic criteria and limitations in diagnosis. Diagn Cytopathol. 1993;9(6): 713-728.
80. Silverman JF, Lannin DR, O'Brien K, et al. The triage role of fine needle aspiration biopsy of palpable breast masses. Diagnostic accuracy and cost-effectiveness. Acta Cytol. 1987;31:731-736.
81. Sneige N. A comparison of fine-needle aspiration, core biopsy and needle localization biopsy techniques in mammographically detectable nonpalpable breast lesions. Pathol Case Rev. 1996;1:6-11.
82. Sneige N. Current issues in fine needle aspiration of the breast: cytologic features of in situ lobular and ductal carcinomas and clinical implications of nuclear grading. Cytopathol Ann. 1992;7:155-171.
83. Sneige N, Staerkel GA. Fine-needle aspiration cytology of ductal hyperplasia with and without atypia and ductal carcinoma in situ. Hum Pathol. 1994;25(5):485-492.
84. Stanley MW, Henry MJ, Zera R. Atypia in breast fine-needle aspiration smears correlates poorly with the presence of a prognostically significant proliferative lesion of ductal epithelium. Hum Pathol. 1993;4(6):630-635.
85. Stanley MW, Lowhagen T. Fine-Needle Aspiration of Palpable Masses. Boston: Butterworth-Heinemann; 1993.
86. Stanley MW, Abele JS. Malpractice vs. benepractice. Am J Surg Path. 1995;19:483-485. Letter.
87. Ulanow R, Galblum L, Canter JW. Fine needle aspiration in the diagnosis and management of solid breast lesions. Am J Surg. 1984;148:6653-6657.
88. Vetto J, Pommier R, Schmidt W, et al. Use of the "triple test" for palpable breast lesions yields high diagnostic accuracy and cost savings. Am J Surg. 1995;169:519-522.
89. Vural G, Hagmar B, Lilleng R. A one-year audit of fine needle aspiration cytology of breast lesions. Factors affecting adequacy and a review of delayed carcinoma diagnoses. Acta Cytol. 1995;39:1233-1236.
90. Zajdela A, Zillhardt P, Voillemot N. Cytological diagnosis by fine needle sampling without aspiration. Cancer. 1987;59: 1201-1205.
91. Zarbo RJ, Howanitz PJ, Bachner P. Interinstitutional comparison of performance in breast fine-needle aspiration cytology. Arch Pathol Lab Med. 1991;115:743-750.